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The HIV-1-specific vpu gene encodes an integral membrane phosphoprotein which affects three aspects of the HIV-1
infectious cycle: it enhances virion release from infected cells; it causes degradation of the CD4 protein in the endoplasmic
reticulum; and it delays syncytia formation in HIV-1-infected CD41 T-cells. Although little is known about how Vpu mediates
these effects, it has been proposed to function as a nonspecific cation channel. In this report, voltage clamp measurements
of Xenopus oocytes show that Vpu expression is not associated with increased transmembrane currents. Instead, Vpu
expression diminishes membrane conductance. Injection of 4.6 ng of Vpu mRNA into these cells reduces endogenous
potassium conductance by 50%. Only Vpu mutants which retain the ability to degrade CD4 can diminish K1 conductance.
Inhibition by Vpu is not unique to K1 channels as it is also observed on several coexpressed membrane proteins but not on
a coexpressed cytoplasmic protein. These results indicate that the CD4 degradative capability of Vpu and the Vpu-mediated
modulation of membrane protein expression are mechanistically coupled and that Vpu may contribute to HIV pathogenesis
by altering plasma membrane protein expression at the cell surface. © 1998 Academic Press
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INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) is a
complex retrovirus that encodes a number of auxiliary
proteins (Tat, Rev, Nef, Vif, Vpr, and Vpu) in addition to the
common retroviral structural proteins Gag, Pol, and Env
(Subbramanian and Cohen, 1994; Trono, 1995). The vpu
gene is unique to HIV-1 and is not encoded in the
genome of the related primate lentiviruses HIV-2 and
most SIVs (Cohen et al., 1988; Strebel et al., 1988; Mat-
suda et al., 1988; Huet et al., 1990). Vpu is expressed late
during virus replication from a bicistronic mRNA that also
codes for the HIV-1 Env glycoprotein precursor gp160.
The coordinate expression of these two proteins was
suggested to reflect a functional requirement (Schwartz
et al., 1990). Though not essential for virus replication in
vitro, expression of Vpu is correlated with a marked
increase in the efficiency of viral particle release from the
surface of infected cells (Strebel et al., 1989; Terwilliger
et al., 1989). Moreover, Vpu delays cytopathic effects
related to the infection of CD41 T-cells with HIV-1 by
reducing the rate of syncytium formation (Klimkait et al.,
1990; Terwilliger et al., 1989). This phenotype was shown
to be directly related to the level of gp120 expressed at
the surface of infected cells (Friborg et al., 1995; Yao et
al., 1993). Vpu also reduces the formation of CD4–gp160
complexes in the ER by inducing the specific degrada-
tion of the CD4 molecule (Willey et al., 1992).
Mutagenic analysis showed that Vpu contains two
functional domains, an N-terminal hydrophobic mem-
brane-spanning domain [amino acids (aa) 1–27] which
modulates viral particle release and a 54-amino-acid
C-terminal hydrophilic cytoplasmic domain which medi-
ates CD4 degradation and modulates the rate of syncy-
tium formation (Friborg et al., 1995; Schubert et al., 1996a;
Schubert and Strebel, 1994). Schubert et al. have dem-
onstrated the presence of two phosphorylation sites,
serine 52 and serine 56, within the cytoplasmic tail of the
protein, the phosphorylation of which is modulated by
casein kinase II (Schubert et al., 1994). Studies aimed at
elucidating the mechanisms underlying the biological
activities of Vpu showed that phosphorylation of Vpu is
essential for its ability to induce CD4 degradation and
mediate the delay in the rate of syncytium formation,
though it was not absolutely required for its release
function (Friborg et al., 1995; Schubert et al., 1996a;
Schubert and Strebel, 1994). Importantly, Vpu-mediated
CD4 degradation is specific as it involves an interaction
of Vpu with CD4 molecules (Bour et al., 1995; Willey et al.,
1992). Several studies have shown that Vpu-mediated
CD4 degradation occurs in the ER and depends on the
presence of both CD4 transmembrane and cytoplasmic
domains (Chen et al., 1993; Lenburg and Landau, 1993;
Vincent et al., 1993; Willey et al., 1994; Yao et al., 1995).
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Vpu-mediated viral release, on the other hand, is inde-
pendent of CD4 expression and is not specific to HIV-1
since Vpu is capable of enhancing the release of viral
particles produced by gag genes encoded by widely
divergent retroviruses (Go¨ttlinger et al., 1993; Yao et al.,
1992). Thus, these two biological activities of Vpu appear
to be modulated by distinct cellular mechanisms. Recent
work has implicated Vpu in the regulation of the mam-
malian secretory pathway (Vincent and Jabbar, 1995).
This study suggested that expression of Vpu interfered
with the transfer of viral glycoproteins from the ER to the
Golgi apparatus in a dose-dependent manner. The study
also demonstrated that this process is mechanistically
related to the CD4 degradative function of Vpu since it
requires the same structural element within the protein.
Vpu possesses structural similarities to the M2 protein
of influenza virus: both are small amphipathic type I
integral membrane phosphoproteins (Singer et al., 1987)
which form homo-oligomeric complexes (Henklein et al.,
1993; Holsinger and Lamb, 1991; Holsinger et al., 1994,
1995; Maldarelli et al., 1993; Strebel et al., 1989; Sugrue
and Hay, 1991). M2 has been shown to function as an ion
channel when expressed in Xenopus laevis oocytes
(Pinto et al., 1992; Wang et al., 1994), which has prompted
the suggestion that Vpu may also act as an ion channel
(Klimkait et al., 1990; Maldarelli et al., 1993; Schubert and
Strebel, 1994; Strebel et al., 1989). Ewart et al. (1996)
demonstrated that Vpu is capable of expressing a non-
specific cation conductance when inserted into lipid bi-
layers and that it appeared to induce a Na1 leak (judging
by induction of a proline leak) when expressed in Esch-
erichia coli, whereas Schubert et al. (1996b) found non-
specific cation currents both following insertion into lipid
bilayers and after expression in Xenopus oocytes. There
are limitations associated with each of these means of
ion current detection; the problems associated with in-
terpreting results obtained from lipid bilayers include the
appearance of currents from aggregates of hydrophobic
peptides which are known not to form ion channels in
vivo (Tosteson et al., 1988). The use of E. coli as an
indirect means of detecting a Na1 leak is compromised
both by the existence of multiple proline permeases (of
varying mechanisms of action) and by the complex
means by which expression of the permeases is con-
trolled (Lucht and Bremer, 1994). Finally, current mea-
surements in Xenopus oocytes have recently demon-
strated the induction of a nonspecific conductance fol-
lowing expression of a wide variety of membrane
proteins (Tzounopoulos et al., 1995; Shimbo et al., 1995),
which represents a response of the cell to the protein
expression and not a genuine current through the exog-
enous protein. To further explore the possibility that Vpu
functions as an ion channel, we expressed the HIV-1 Vpu
protein in Xenopus oocytes in order to measure current
flows associated with the presence of this protein. We
found that expression of Vpu in oocytes did not induce
any measurable ionic conductance other than occasion-
ally demonstrating the nonspecific conductance de-
scribed above. Instead, a pronounced inhibition of po-
tassium conductance was associated with the expres-
sion of Vpu. The characterization of this inhibition
suggests that Vpu has a negative effect on the expres-
sion of endogenous membrane proteins in host cells.
RESULTS
Effects of Vpu on membrane conductance
To measure the effect of Vpu expression on conduc-
tance in Xenopus oocyte plasma membranes, we used a
two-microelectrode voltage clamp, which permits the
measurement of current flow at defined membrane po-
tentials. When the Vpu protein was expressed in Xeno-
pus oocytes there was no evidence of an induced ionic
conductance after 1 to 4 days following injection; in-
stead, Vpu diminished conductance across the cell
membrane at all potentials tested compared to control
oocytes (Fig. 1A). All control oocytes were injected with
water, and the currents measured were indistinguishable
from those seen with uninjected oocytes (data not
shown). The current inhibited by Vpu has a reversal
potential of approximately 270 mV (Fig. 1B), close to the
K1 reversal potential in Xenopus oocytes which we had
previously measured to be 275 mV under the conditions
used in our laboratory (Huang et al., 1995), and this effect
has regularly and repeatedly been observed in these
experiments (Fig. 1C). Thus, Vpu expression inhibits an
ionic conductance in oocytes, and the conductance ap-
pears to be specific for potassium.
Ionic conductances affected by Vpu
The diminished ionic conductance was identified by
altering the external Na1, K1, and Cl2 concentrations.
The I–V curves for oocytes in normal frog saline solution
or in a solution where half of the Na1 had been replaced
by N-methyl-D-glucamine (NMDG) were identical (data
not shown). This is true for both control oocytes and
oocytes expressing Vpu, indicating the low level of en-
dogenous Na1 conductance. Replacement of external
Cl2 by cyclamate caused a small diminution in current at
positive potentials but the decrease in current was iden-
tical for both control and Vpu-expressing oocytes (Fig.
2A). An increase in the external K1 concentration from 3
to 53 mM caused a large increase in conductance
across the oocyte membrane (Fig. 2B), as would be
expected since potassium channels represent the major
ionic conductance found in the oocyte membrane (Das-
cal, 1987). However, the increase in conductance due to
high external K1 concentrations was severely dimin-
ished for Vpu-expressing oocytes. Furthermore, the in-
tersection between the I–V curves for control and Vpu-
expressing oocytes changed in general synchrony (260
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mV for 3 mM external K1 and 214 mV at 53 mM external
K1) with the reversal potential for K1 currents. On the
basis of these data, the currents inhibited by Vpu must
be carried by K1 channels.
Effect of varying Vpu mRNA quantities
To determine an optimal concentration of Vpu mRNA
as well as to measure dose-dependent effects of Vpu
mRNA expression, we injected different amounts of
mRNA in 46-nl aliquots and measured the resulting cur-
rents. The largest amount employed (46 ng) is often used
in the expression of exogenous proteins in Xenopus
oocytes, but proved uniformly lethal within 2 days when
used with Vpu mRNA. Similarly, 23 ng of Vpu mRNA killed
approximately half of the oocytes within 2 days, while
lower amounts of mRNA were not lethal. Injection of 4.6
ng (or more) of Vpu mRNA caused maximal inhibition of
conductance, while lower amounts of mRNA yielded in-
termediate levels of current inhibition (Fig. 3A). The
amount of Vpu mRNA required to induce one-half of the
maximal inhibition at 150 mV was approximately 0.5 ng.
Immunoprecipitation of the Vpu present in oocytes in-
jected with varying quantities of mRNA did not regularly
yield measurable amounts of the protein unless at least
2.3 ng mRNA was used (Fig. 3B), and commensurately
larger amounts of Vpu were made with larger quantities
of mRNA despite the constant level of current inhibition
at these mRNA concentrations. The optimal amount of
mRNA was determined to be 4.6 ng since larger quanti-
ties routinely induced a large hyperpolarization-activated
nonspecific cation (HANC) current at negative potentials,
which has been shown to be a common artifact when
overexpressing many membrane proteins in Xenopus
oocytes (Tzounopoulos et al., 1995; Shimbo et al., 1995).
FIG. 1. Vpu inhibits oocyte membrane conductance. (A) Current tracings elicited from two typical oocytes from the same donor. Tracings on the left
were taken from an oocyte 2 days following injection with water; tracings on the right were from an oocyte injected with 4.6 ng of wild-type Vpu
(VpuWT) mRNA. All currents were measured by holding the oocyte at a potential of 250 mV and then clamping the voltage with steps from 175 to
2175 mV in 25-mV increments. (B) Average current–voltage (I–V) curves for a group of Vpu (n 5 3) and control (n 5 3) oocytes. The results shown
are from oocytes measured during one arbitrarily chosen day and are typical of a large body of experiments carried out over a period of months. (C)
Current measurements at 150 mV membrane potential are shown for Vpu-expressing and control oocytes taken from four different animals. Each
symbol and error bar represents the mean and SEM for three oocytes from an individual donor and lines join the equivalent symbols representing
oocytes used from each donor for the two injected groups. Note that the background level of current varies between animals but that Vpu expression
invariably produces a diminished level of conductance. Analysis of the results via two-way ANOVA showed a significant current inhibition due to Vpu
expression (P , 0.01).
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Although there is some disagreement as to the ionic
selectivity of this conductance, it appears to nonspecifi-
cally pass monovalent cations with some divalent cation
conductance, which causes stimulation of the oocyte’s
Ca21-sensitive chloride channels (Tzounopoulos et al.,
1995; Shimbo et al., 1995). The HANC conductance is
slowly activated, somewhat variable, and constantly in-
creasing; hence, sequential measurements of this cur-
rent at a particular time period from the same cell yield
differing levels of current. When injecting 4.6 ng of
VpuWT mRNA, the HANC conductance was found in 11
of 20 oocytes at 2 days following injection and in 5 of 20
oocytes which had been injected with water at the same
time.
Temporal expression of Vpu
Vpu expression was monitored over 5 days following
the injection of 4.6 ng of Vpu mRNA by immunodetection
on Western blots as well as by two-microelectrode volt-
age clamping. The amount of Vpu is highest in the oocyte
at 1 day following mRNA injection and then steadily
decreases to a minimal level between days 3 and 5 (Fig.
4A). Generally, an immunoprecipitable product remains
visible at days 3 and 4. The current inhibition caused by
Vpu expression reflects this pattern, demonstrating a
maximal effect at 1 and 2 days after injection and then
decreasing to a negligible effect by day 5 (Figs. 4B and
4C). The presence of the HANC conductance at negative
potentials, which is related to the amount of the exoge-
nous membrane protein, is also most often found at 1
day after injection (Figs. 4B and 4C). The Vpu mRNA
and/or protein are somewhat unstable in oocytes since
both measurable Vpu and Vpu-induced current inhibition
generally disappear around 5 days after injection of
mRNA, whereas most proteins, when expressed in Xe-
nopus oocytes, reach maximal expression at this time.
Expression of Vpu mutants
To examine the specificity and significance of Vpu’s
ability to inhibit K1 channels, we employed mutated
versions of Vpu which are deficient in known biological
functions of this protein (Fig. 5A). VpuRND has been
mutated such that the transmembrane sequence in the
amino terminal domain is randomized; this mutant form
of Vpu, which is integrated normally into membranes,
lacks the ability to enhance viral release but retains the
FIG. 3. Expression of different amounts of Vpu in oocytes. (A) Effects
on membrane conductance. Currents at a potential of 150 mV were
measured in frog saline solution 2 days following injection of 46 nl of
water containing various quantities of Vpu mRNA. The data were fitted
using saturating kinetics. (B) Detection of Vpu product in injected
oocytes. Immunoprecipitation and Western blot analysis of oocytes
injected with the samples described in A.
FIG. 2. Ionic specificity of the Vpu effect. Experiments were per-
formed in frog saline solution with changes as described. Oocytes
were injected with either water or water containing 4.6 ng of Vpu
mRNA. (A) The effects of reducing Cl2 from 96 to 13 mM (replacement
with cyclamate) are minimal and no difference is seen between control
and Vpu-expressing oocytes. (B) Increasing K1 from 3 to 53 mM
(replacing NMDG, Na1 maintained at 40 mM) causes an increase in
conductance which is largely inhibited by Vpu expression. Three oo-
cytes were used to derive the mean current and SEM shown for each
point.
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ability to mediate CD4 degradation (Schubert et al.,
1996a). Vpu56 has been mutated so as to delete the
phosphorylation site Ser56 in the carboxy terminal cyto-
plasmic domain, and it lacks the ability to mediate CD4
degradation but retains the ability to enhance viral re-
lease (Friborg et al., 1995; Schubert et al., 1994). The
mutant Vpu2 lacks the start codon of Vpu and does not
express any protein. Following injection of 4.6 ng of each
of the mutant Vpu mRNAs into oocytes, VpuRND was
capable of inhibiting the K1 conductance of Xenopus
oocytes identically to that seen with wild-type Vpu
(VpuWT) across the range of potentials used (Fig. 5B).
Only a small inhibition of K1 conductance was seen
following expression of Vpu56 or Vpu2 (Fig. 5C); a similar
effect was seen with the expression of rBAT, an unre-
lated membrane protein, suggesting that the small re-
sponse seen with these three mRNA species is a non-
specific result of the injection of exogenous mRNA. The
disparity between VpuWT and these Vpu mutants was
most obvious when higher external K1 concentrations
were used but could also be seen with 3 mM external
KCl (data not shown). Western blot analysis showed that
the Vpu56 protein was present in quantities slightly
larger than those of VpuWT or VpuRND (Fig. 5A). No Vpu
FIG. 4. Temporal expression of Vpu in Xenopus oocytes. Oocytes were injected with water or water containing 4.6 ng of vpu mRNA. (A) Western
blots of oocytes at various intervals following injection. (B) Current tracings from individual control (left) and Vpu (right) oocytes, measured 1 day
following RNA injection. Note the slow activation of the HANC conductance at hyperpolarized potentials in the Vpu-expressing oocyte. (C) Comparison
of the magnitude of currents at 2175 and at 150 mV during the days following injection of 4.6 ng of RNA. White and black bars represent currents
measured from oocytes injected with water and Vpu mRNA, respectively. The IHANC (large inward current found at 2175 mV) was greater in
Vpu-expressing oocytes than in control oocytes and was found only sporadically in this batch of oocytes. The IVPU is a current which is diminished
in the Vpu-expressing oocytes and is shown here for currents measured at 150 mV. Asterisks represent statistical significant differences between
Vpu and control oocytes (P 5 0.05, measured using paired t tests).
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was detectable from oocytes injected with Vpu2. Since
similar quantities of Vpu56 and VpuWT were detected on
the Western blot and since Vpu56 does not display the
same inhibition of current as is found with VpuWT, we
can conclude that (i) any difference between the effects
of expressing VpuWT and Vpu56 must stem from the
biological activities of Vpu and not from nonspecific ef-
fects caused by the injection and translation of this
membrane protein and (ii) Vpu56 should serve as an
ideal negative control when measuring the biological
effects of VpuWT on K1 conductance. The currents mea-
sured in the presence of the Vpu mutants demonstrate
that the K1 channel inhibition by Vpu appears to be
dependent on the cytoplasmic domain of the protein and
thus could be related to the CD4 degradative effect of
this protein but not to its viral release function.
Coexpression with Vpu
The inhibition of oocyte K1 channels may stem from
two forms of interaction, either the inhibition of the ac-
tivity of the K1 channel itself or decreased expression of
the protein at the plasma membrane. To differentiate
between these two possibilities, we coinjected mRNA
coding for VpuWT or Vpu56 along with mRNA coding for
either of the membrane proteins SGLT1 or rBAT or for the
cytoplasmic protein luciferase. Experiments were per-
formed 3 days following injection to allow higher ac-
tivities of the proteins encoded for by the coinjected
mRNAs. Small amounts of each mRNA (4.6ng) were used
to minimize translation competition with VpuWT mRNA.
Indeed, Western blot analysis showed that the quantities
of VpuWT and Vpu56 were not diminished by coinjection
of the other RNA samples (data not shown). It can be
seen that both SGLT1 and rBAT activities, as measured
with two-microelectrode recordings, are diminished
when VpuWT is coexpressed compared to Vpu56,
whereas the expression of luciferase is increased, an
effect which appears to be nonspecific as all coinjected
mRNAs increased luciferase expression (Figs. 6A–6C).
Since it is highly unlikely that the Vpu protein acts by
specifically inhibiting all of the membrane proteins
SGLT1 and rBAT and the endogenous K1 channels of the
oocyte, it presumably acts by diminishing the expression
of membrane proteins at the oocyte surface.
DISCUSSION
There have been problems associated with previous
attempts to investigate the possibility that Vpu functions
as an ion channel; for instance, although insertion of
full-length Vpu into lipid bilayers has been shown to
induce a cation conductance across the bilayer (Ewart et
al., 1996; Schubert et al., 1996b), the nonspecific currents
measured appear similar to those caused by lipidic
pores associated with improper insertion of non-ion
channel forming peptides into the bilayer (Tosteson et al.,
1988). The measurement of Vpu-associated Na1 channel
activity in bacteria relied on the presence of a single
Na1/proline cotransporter which should extrude proline
if the intracellular Na1 concentration becomes suffi-
ciently high. This approach is flawed in that E. coli con-
tains three different proline cotransporters, and two use
H1 as a counterion. In addition, they are all tightly con-
trolled by osmolarity, which would likely be strongly al-
tered by a large influx of Na1 ions (Lucht and Bremer,
1994). The most common approach to the expression of
ion channels uses Xenopus oocytes (Dascal, 1987) as a
host cell, and this system was used recently to examine
ionic conductance following expression of Vpu (Schubert
FIG. 5. Expression of mutant forms of Vpu. To enhance detection of
K1 channel inhibition, the K1 was increased to 53 mM, keeping Na1 at
40 mM. Oocytes were injected with water or water containing 4.6 ng of
mRNA. (A) Western blots of oocytes injected with water, Vpu-, VpuWT,
VpuRND, or Vpu56. (B) I–V curves for oocytes injected with water,
VpuWT mRNA, or VpuRND mRNA. The VpuWT data are largely coinci-
dent with the VpuRND data. (C) I–V curves for oocytes injected with
water, VpuWT, mRNA, Vpu56, mRNA, or Vpu2 mRNA.
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et al., 1996b). Although the authors identified an induced
ion channel activity following expression of both Vpu and
a Vpu mutant lacking the two phosphorylation sites, the
slowly activating, hyperpolarization-dependent conduc-
tance appears to be identical to the HANC conductance,
an artifact associated with expression in Xenopus oo-
cytes of exogenous membrane proteins. This possibility
was refuted by the authors, who demonstrated that an-
other Vpu mutant (R2/6) did not display this activity de-
spite being present in the oocyte at high levels and also
proved that their conductance was not chloride-depen-
dent. However, it has been shown that some proteins,
e.g., the M2 protein, can be present in the oocyte at high
levels without inducing HANC currents and yet two sim-
ple mutations of this protein (into the Syn-C mutant)
create a protein whose expression induces HANC cur-
rents (Shimbo et al., 1995). Consequently, it is quite
possible that the large mutations created in the R2/6
protein (one-third of the protein has been randomized)
have eliminated whatever induces the HANC conduc-
tance. One other viral protein (NB) which had been
shown to induce conductance in lipid bilayers (Sunstrom
FIG. 6. Coexpression of Vpu with other proteins. All oocytes were injected with water or with water containing 4.6 ng of each of the mRNA species
required. (A) Effect of Vpu on SGLT1 currents. SGLT1 currents are defined as those induced at 2100 mV by the addition of 1 mM a-methylglucoside
(aMG). (B) Effect of Vpu on rBAT currents. rBAT currents are defined as those induced at 150 mV by addition of 2 mM alanine. (C) Effect of VpuWT,
Vpu mutants, and SGLT1 on luciferase expression. Luciferase was measured as previously described (Miele et al., 1996). Asterisks indicate
statistically significant difference from luciferase expressing oocytes (P 5 0.05, Student–Neuman–Keuls test).
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et al., 1996) did not change ionic conductance when
expressed in Xenopus oocytes except through increased
HANC conductance (Shimbo et al., 1995). Furthermore,
the ionic specificities of the HANC conductance are not
yet clear. Although it is associated with chloride tail
currents, these can be deleted by removal of calcium
from the external solution without causing large changes
to the HANC conductance itself, indicating that HANC is
not likely a simple chloride channel. In our hands, a
current similar to that observed by Schubert et al. (1996b)
was observed in approximately half of the oocytes ex-
pressing Vpu and in a quarter of the oocytes injected
with water; it is noteworthy that this current also seems
to be only occasionally present in the hands of Schubert
et al. (1996b), whereas we have found the inhibitory
effect of Vpu on K channels to be present in all Vpu-
expressing oocytes. The increased conductance at hy-
perpolarized potentials, when present in either water- or
Vpu-injected oocytes, appears identical to that described
by Schubert et al. as well as to the artifactual currents
described previously (Tzounopoulos et al., 1995; Shimbo
et al., 1995). The similarity between the currents ob-
served by all groups (hyperpolarization-activated, non-
specific conduction and slow activation), and the fact
that they can also be observed in water-injected oocytes,
suggests that the currents described by Schubert et al.
actually represent HANC currents, which are a frequent
consequence of the expression of membrane proteins in
Xenopus oocytes.
There are considerable differences between the ex-
pression of the Vpu-mediated current inhibition and of
the HANC conductance: (i) the HANC conductance rep-
resents an increase in total oocyte membrane conduc-
tance, whereas the Vpu effect is an inhibition of total
oocyte membrane conductance, (ii) the HANC conduc-
tance was generally observed in Vpu-expressing oocytes
when the amount of Vpu protein was maximal, but even
when it was occasionally present (e.g., 2 days following
injection of 4.6 ng of Vpu mRNA) the inhibitory effect of
Vpu on K1 conductance was routinely observed (see Fig.
4C), (iii) the inhibitory effect of Vpu is specific for K1
conductance, whereas the HANC conductance is not
specific to any cation, (iv) the Vpu-induced inhibition is
not dependent on hyperpolarization and was readily ob-
served on the steady-state conductance of the oocyte,
whereas the HANC current requires hyperpolarization
and displays continual, slow activation over a period of
seconds. For these reasons, the inhibitory effect of Vpu
seems to be completely different from the HANC con-
ductance and is not a nonspecific consequence of ex-
ogenous protein expression.
It is interesting that the Vpu effects are strongest the
day following injection and then diminish; many other
membrane proteins, when expressed in Xenopus oo-
cytes, demonstrate the greatest expression at 4 to 6 days
following injection (Tzounopoulos et al., 1995). The rapid
disappearance of Vpu in the oocytes suggests that the
mRNA and/or the protein itself must be relatively unsta-
ble. We do not know whether the putative mRNA insta-
bility could be attributable to the coding region of Vpu
itself or to the untranslated and polyadenylated se-
quences associated with it in our construct. We suspect
that both the transient nature of the Vpu-mediated cur-
rent inhibition and differences in translational efficiency
between the construct used here and that used else-
where (Schubert et al., 1996b) may partially explain why
(i) the inhibition observed here was not found by others
and (ii) injection of 46 ng of Vpu mRNA was uniformly
lethal to oocytes in this study but was routinely used by
Schubert et al. It is also noteworthy that a maximal
inhibition of K channel conductance is achieved by in-
jecting 4.6 ng of Vpu mRNA, although larger amounts of
protein were detected following the injection of larger
quantities of mRNA. Although this suggests that some
cellular biochemical pathway is saturated by Vpu at low
levels of injected Vpu mRNA, there is as yet no evidence
to support this.
The availability of functional mutants for Vpu allowed
the K1 channel inhibition to be associated with the CD4
degradative capacity of Vpu. A mutant form of Vpu which
cannot enhance CD4 degradation (Vpu56) is only capa-
ble of inhibiting K1 conductance to a small extent, similar
to that seen with noncoding mRNA or mRNA coding for
an unrelated protein. This indicates that the mutant pro-
tein must lack the specific inhibitory activity of Vpu since
Vpu56 is sufficiently stable for detection by Western blot.
More importantly, this demonstrates that the inhibition of
K conductance by Vpu expression must be a specific
biological function of the Vpu protein and not simply due
to competition between Vpu and K channels at the levels
of translation, posttranslational processing or intra-
cellular trafficking, since Vpu56 is translated to the
same extent and has been shown to be located in the
same intracellular locations as VpuWT (Schubert et al.,
1996a; J. Friborg, unpublished observations). Conversely,
VpuRND, which does not enhance virus release but
which possesses CD4 degradative capability (Schubert
et al., 1996a), demonstrates currents which are indistin-
guishable from those of VpuWT-expressing oocytes. The
inhibition of K1 conductance in oocytes by Vpu is appar-
ently related to its CD4 degradative effect by the carboxyl
terminal cytoplasmic region of the protein and not to the
enhancement of virus release by the transmembrane
amino terminal region of this protein. Vpu-mediated in-
hibition of K1 conductance and its mediation of CD4
degradation appear to require the same structural ele-
ments in Vpu and thus these two processes could be
mechanistically coupled.
The possibility that Vpu-mediated inhibition of K1
conductance occurs not by direct channel inhibition
but by diminishing expression of the K1 channels at
the oocyte surface appears plausible since (i) Vpu
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does not accumulate at the cytoplasmic membrane of
the producer cell line (where K1 channels are found)
except under conditions of overexpression, (ii) other
work has found that Vpu (but not a mutated Vpu which
lacks the ability to degrade CD4) can interfere with
viral membrane protein trafficking (Vincent and Jabbar,
1995), where Vpu expression blocked the transfer of
protein from the ER to the Golgi complex, and (iii) the
K1 channels of Xenopus oocytes, which represent the
major class of ion channels in these cells, have been
reported to be labile and to undergo rapid down-
regulation following progesterone stimulation (Dascal,
1987). Although the inhibitory effect of Vpu on K1
channels is part of a broader inhibition of membrane
protein expression, cytoplasmic luciferase expression
is not inhibited by either VpuWT or Vpu56. At this time
we are unable to say whether the diminished expres-
sion of membrane proteins mediated by Vpu reflects
changes in the biosynthesis (Kerkau et al., 1997), traf-
ficking (Vincent and Jabbar, 1995), or stability (Willey et
al., 1992) of membrane proteins.
Although our data does not support a Vpu ion channel
activity, we cannot rule out the possibility that Vpu might
function as an intracellular ion channel since the two-
microelectrode system used here only detects current
across the plasma membrane. It is, however, clear that
Vpu, unlike the M2 protein, does not function as an ion
channel at the cell surface. We have also shown that the
inhibition of K1 channels in Xenopus oocytes by Vpu is
unlikely to be due to a direct biological interaction be-
tween Vpu and these channels, but simply reflects the
diminished expression of membrane proteins in the
presence of Vpu. The most apparent consequence of the
diminution of membrane protein expression by Vpu
would be a decreased expression of Env at the surface
of virally infected cells. This phenomenon could explain
the decreased formation of syncytia associated with Vpu
expression as well as the fact that CD4 degradation does
not require Brefeldin A for retention in the endoplasmic
reticulum when Vpu is overexpressed. Furthermore, de-
creased trafficking of membrane proteins might be im-
portant in aiding the Vpu protein in the degradation of
CD4 by impeding passage of CD4 from the endoplasmic
reticulum where it is degraded (Vincent and Jabbar,
1995). Interestingly, a recent report showed that Vpu (but
not a phosphorylation-minus Vpu mutant) interferes with
an early step in the biosynthesis of major histocompati-
bility complex (MHC) Class I molecules and thus con-
tributes to the previously observed decrease in the ex-
pression of MHC-I molecules on the surface of HIV-1-
infected cells (Kerkau et al., 1997). Experiments aimed at
understanding the molecular mechanism by which Vpu




Oocytes were removed from mature X. laevis and de-
folliculated as described previously (Coady et al., 1996)
with the exception that the oocytes were maintained at
18°C in Barth’s solution (90 mM NaCl, 3 mM KCl, 0.82
mM MgSO4, 0.41 mM CaCl2, 0.33 mM Ca(NO3)2, 5 mM
HEPES, pH 7.6) in the absence of antibiotics. All samples
of water or RNA were injected into the oocytes in 46-nl
aliquots. RNA concentrations were determined by ultra-
violet spectroscopy and confirmed using denaturing aga-
rose gel electrophoresis.
Site-directed mutagenesis, construction of
recombinant plasmids, and in vitro RNA synthesis
The Vpu cDNAs used in this study were derived from
previously produced recombinant plasmids: VpuWT (Ter-
williger et al., 1989), Vpu2 (Terwilliger et al., 1989), and
Vpu56 (Friborg et al., 1995). The VpuRND was generated
by polymerase chain reaction (PCR) as described by
Schubert et al. (1996). To produce Vpu cDNAs for this
work, a set of oligonucleotide primers located 24 bp
upstream of the vpu initiation codon (sense primer A:
59-C A G T C T A G A G T A C A T G T A A T G C A A-39)
and 35 bp downstream from the vpu termination codon
(antisense primer B: 59-C A C A C A G G A T C C C C A
T A A-39) were used to generate the DNA fragments
encoding VpuWT, Vpu56, and VpuRND in order to insert
them into the plasmid pBluescript (SK1) (Stratagene, San
Diego CA), which had been cleaved with XbaI and
BamHI. The plasmid used had been modified to contain
a poly (A) sequence between the BamHI and EcoRI sites
that was taken from the pSP64polyA vector (Promega,
Madison WI). A Vpu2 fragment was amplified using a
sense primer lacking an initiation codon (C: 59-C A G T C
T A G A G T A C A T G T A C T G C A A) and the same
antisense B primer described above. Following subclon-
ing into pBluescript (SK1), DNA sequencing was per-
formed on an Applied Biosystems, Inc. (Foster City, CA)
Model 373A automated DNA sequencer using the uni-
versal SK primer. For in vitro transcription, plasmid DNAs
were linearized using the EcoRI restriction site down-
stream of the Vpu cDNA insert and the poly (A) site.
Genetic constructs for (i) the sodium/glucose cotrans-
porter (SGLT1), (ii) the ‘‘related to b0, 1’’ amino acid trans-
porter (rBAT), and (iii) luciferase are described elsewhere
(Bissonnette et al., 1996; Coady et al., 1994; Miele et al.,
1996). In vitro synthesis of capped mRNA was performed
using the T3 mMessage mMachine system (Ambion,
Austin TX). Unless otherwise specified, mRNA was in-
jected at a concentration of 0.1 mg/ml. All control oocytes
were injected with water.
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Immunoblotting analysis and SDS–PAGE
For immunoblotting of oocyte lysates, eight oocytes
from each experimental group were lysed in 600 ml of
RIPA buffer and extracted once with 1,1,2-trichlorotriflu-
oroethane to remove yolk and pigment proteins. The
aqueous layer was removed and immunoprecipitated
with a rabbit anti-Vpu peptide serum directed against the
C-terminal region of the Vpu protein (HAPWDVDDL) for
1 h to concentrate the Vpu protein (Cohen et al., 1988).
Protein A–Sepharose beads (50 ml) were added and
gently agitated for 1 h at 4°C. The immunocomplexes
were washed, solubilized in loading buffer [62.5 mM
Tris–HCl pH 6.8, 0.2% sodium dodecyl sulfate (SDS), 5%
2-mercaptoethanol, 10% glycerol], boiled for 5 min, and
separated on a 12.5% SDS–polyacrylamide gel. Follow-
ing electrophoresis, proteins were transferred to nitro-
cellulose (0.45-mm pore size; Schleicher & Schuell) by
electroblotting (45 min, 100 V at constant current in a
Bio-Rad Trans Blot cell). Blots were incubated for 1 h at
room temperature in blocking buffer [5% nonfat dry milk
in phosphate-buffered saline (PBS) 1 0.5% Tween] and
then for 2 h with an anti-Vpu antibody diluted 1:3000.
Protein bound antibodies were probed with horseradish
peroxidase-linked sheep anti-rabbit immunoglobulin
(used at 1:2000 dilutions), washed extensively, and de-
veloped by using an enhanced chemiluminescence de-
tection system as recommended by the manufacturer
(Amersham).
Two-microelectrode recording
Standard procedures were used for performing two-
microelectrode voltage clamp recordings with oocytes
(Coady et al., 1996). Unless otherwise specified, currents
were measured in frog saline solution (83 mM NaCl, 7
mM NMDG-Cl, 3 mM KCl, 0.82 mM MgCl2, 0.74 mM
CaCl2, 5 mM HEPES pH 7.6). An agarose bridge was
used for all measurements except for those where the
identity of the ionic species involved was determined; for
these experiments a free-flowing pipette containing 3 M
KCl was used and positioned downstream from the oo-
cyte. Only oocytes with a stable membrane potential
more negative than 230 mV were used. Currents were
measured and analyzed using a commercially available
data acquisition system and software (R.C. Electronics,
Inc., Goleta CA). Data were averaged across a 20-ms
interval toward the end of the 500-ms pulse. Due to the
variability in currents between batches of oocytes from
different donors, all figures (unless described otherwise)
are from representative experiments where each symbol
represents the mean 6 SEM of three oocytes from one
donor; each figure shown has been reproduced in at
least three separate sets of experiments using oocytes
from different donors. Error bars are shown in most
figures, but are often smaller than the symbols used.
Unless otherwise stated, all experiments were per-
formed 2 days following injection of mRNA.
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